Actinogen Medical Limited - ROE
ATGGF
Price:
$0.0008
Market Cap:
$156.13M
Actinogen Medical Limited is an Australian biotechnology firm specializing in the creation of treatments for neurological and neuropsychiatric conditions linked to abnormal brain cortisol levels. Their primary therapeutic candidate, Xanamem, functions as an inhibitor of the 11ß-HSD1 enzyme. Currently in Phase 2 clinical trials, Xanamem has shown the ability to engage its intended target within the central nervous system. Its development focuses on addressing Alzheimer's disease, cognitive impairment associated with depression, and the anxiety, sleep, and behavioral challenges seen in fragile X syndrome. Founded in 1999, the company, based in Sydney, Australia, operated as Actinogen Limited u...[Read more]
Industry
Biotechnology
IPO Date
2018-09-18
Stock Exchange
OTC
Ticker
ATGGF
PE Ratio
[-0.21]
ROE
[-134.14%]
Current Ratio
[4.19]
Dividend Yield
[0%]
Enterprise Value
[149.97M]
Dividend History
The ROE as of August 2026 (TTM) for Actinogen Medical Limited (ATGGF) is -134.14%
According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current ROE is -134.14%. This represents a change of 151.88% compared to the average of -53.25% of the last 4 quarters.
Actinogen Medical Limited (ATGGF) Historical ROE (quarterly & annually)
How has ATGGF ROE performed in the past?
The mean historical ROE of Actinogen Medical Limited over the last ten years is -50.51%. The current -134.14% ROE has changed 165.57% with respect to the historical average. Over the past ten years (40 quarters), ATGGF's ROE was at its highest in in the January 2008 quarter at 0%. The ROE was at its lowest in in the June 2012 quarter at -220.35%.
Average
-50.51%
Median
-46.32%
Minimum
-80.35%
Maximum
-22.43%
Actinogen Medical Limited (ATGGF) ROE by Quarter and Year
Discovering the peaks and valleys of Actinogen Medical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.81%
Maximum Annual ROE = -22.43%
Minimum Annual Increase = -54.19%
Minimum Annual ROE = -80.35%
| Year | ROE | Change |
|---|---|---|
| 2025 | -80.35% | 21.32% |
| 2024 | -66.23% | -17.42% |
| 2023 | -80.20% | 83.58% |
| 2022 | -43.69% | 94.81% |
| 2021 | -22.43% | -54.19% |
| 2020 | -48.96% | -22.44% |
| 2019 | -63.12% | 74.84% |
| 2018 | -36.10% | 5.99% |
| 2017 | -34.06% | 13.67% |
| 2016 | -29.97% | -15.26% |
Actinogen Medical Limited (ATGGF) Average ROE
How has ATGGF ROE performed in the past?
The current ROE of Actinogen Medical Limited (ATGGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-75.59%
5-year avg
-58.58%
10-year avg
-50.51%
Actinogen Medical Limited (ATGGF) ROE vs. Peers
How is ATGGF’s ROE compared to its peers?
Actinogen Medical Limited’s ROE is greater than Nicox S.A. (-51.16%), greater than Clara Technologies Corp. (-84.68%), less than Vicapsys Life Sciences, Inc. (8.65%), greater than IXICO plc (-16.18%), greater than Alterity Therapeutics Limited (-30.19%), less than ZIVO Bioscience, Inc. (204.08%), greater than BioStem Technologies, Inc. (-47.03%), less than MindMaze Therapeutics Holding S.A. (0%), greater than Amplia Therapeutics Limited (-18.71%), greater than Helix BioPharma Corp. (-21.54%),
| Company | ROE | Market cap |
|---|---|---|
| -51.16% | $29.17M | |
| -84.68% | $3.60M | |
| 8.65% | $46.94M | |
| -16.18% | $6.51M | |
| -30.19% | $76.13M | |
| 204.08% | $15.55M | |
| -47.03% | $56.62M | |
| 0% | $5.30M | |
| -18.71% | $44.14M | |
| -21.54% | $130.61M |
Build a custom stock screener for Actinogen Medical Limited (ATGGF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Actinogen Medical Limited (ATGGF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Actinogen Medical Limited's ROE?
How is the ROE calculated for Actinogen Medical Limited (ATGGF)?
What is the highest ROE for Actinogen Medical Limited (ATGGF)?
What is the 3-year average ROE for Actinogen Medical Limited (ATGGF)?
What is the 5-year average ROE for Actinogen Medical Limited (ATGGF)?
How does the current ROE for Actinogen Medical Limited (ATGGF) compare to its historical average?